About
Yoel is a corporate senior associate in our Global M&A and Capital practice in London, specialising in advising FTSE clients and international corporates on cross-border M&A transactions, joint ventures and general corporate and listed company matters.
During his time with Freshfields, Yoel has spent time on secondment to the M&A legal team at a leading international defence company.
Additional Information
Yoel's experience includes advising:
- Octopus Energy on the spin out and first standalone investment round into its world-leading AI-powered operating platform Kraken, valuing Kraken at $8.65bn.
- bp on the sales of non-controlling stakes in bp Pipelines TAP and bp Pipelines TANAP to funds managed by Apollo, in separate transactions valued at c.US$1bn each.
- BAE Systems on:
- its strategic business joint venture with Leonardo and Japan Aircraft Enhancement Co to design, develop and deliver the next generation combat aircraft under the Global Combat Air Programme; and
- Air Astana's $847 million IPO and listings on the London Stock Exchange, Astana International Exchange and Kazakhstan Stock Exchange.
- London Stock Exchange Group on:
- its 10-year, multi-billion pound strategic collaboration with Microsoft for next-generation data, analytics and cloud infrastructure solutions;
- multiple on-market share buyback programmes; and
- the exit by the Blackstone/Thomson Reuters consortium (the former Refinitiv shareholders), including the monetisation by the former Refinitiv shareholders of approximately £11.5bn through block trades and directed buybacks.
- Affiliated Managers Group on its minority investment in Qualitas Energy.
- Rentokil Initial on its $6.7bn acquisition of Terminix.
- Cazoo on its $7bn de-SPAC and US listing and various strategic bolt-on acquisitions.
- AstraZeneca on its $39bn acquisition of Alexion Pharmaceuticals.
- Novartis on the acquisition by Sandoz of GSK's cephalosporin antibiotics business.
Yoel Gordon
Senior Associate
London Office
100 Bishopsgate
London EC2P 2SR